撤稿:澳大利亚与新西兰血管外科学会股-髂-腔静脉静脉流出道梗阻临床实践指南
该指南由澳大利亚与新西兰血管外科学会制定,通过问卷调查当地实践、综述国际共识指南并投票形成推荐,聚焦静脉支架置入的患者选择与技术方面,提出CEAP≥3或疼痛VCS≥2且影像狭窄>50%等推荐条款。
要点
- CEAP≥3或疼痛VCS≥2且影像狭窄>50%者应考虑静脉支架置入(推荐Ib级)。
- 急性髂股深静脉血栓清除术中发现狭窄病变者应考虑静脉支架置入(推荐Ib级)。
- 无症状患者不应提供静脉支架置入(推荐IIIc级)。
核心结论
- 深静脉流出道梗阻长期被低估和治疗不足,近年来治疗选择进步但培训未同步增长,本指南旨在建立诊疗标准并为未来发展提供教育平台。
研究设计与样本
- 由澳大利亚与新西兰血管外科学会对当地血管外科医生进行问卷调查,比较国际共识指南并补充静脉支架关键研究后投票形成推荐。
主要发现
- 文件涵盖患者选择与静脉支架技术两个方面,并识别了指南适用性的障碍。
关键数值与推荐
- CEAP评分≥3或疼痛静脉临床严重程度评分≥2(或两者兼有),且静脉造影、CT静脉造影、MR静脉造影和/或血管内超声显示狭窄>50%的患者应考虑静脉支架置入(推荐Ib级)。
- 急性髂股深静脉血栓清除术中发现狭窄病变的患者应考虑静脉支架置入(推荐Ib级)。
- 慢性盆腔痛、深部性交痛、影响生活质量的性交后疼痛且排除其他原因的患者应考虑静脉支架置入(推荐Ic级)。
- 无症状患者不应提供静脉支架置入(推荐IIIc级)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The overall goal of this report is to provide a high-level, practical approach to managing venous outflow obstruction (VOO) in Australia and New Zealand. METHODS: A group of vascular surgeons from the Australian and New Zealand Society for Vascular Surgery with specific interest, training, and experience in the management of VOO were surveyed to assess current local practice. The results were analyzed and areas of disagreement identified. Following this, the group performed a literature review of consensus guidelines published by leading international organizations focused on the management of chronic venous disease, namely the Society for Vascular Surgery, American Venous Forum, European Society for Vascular Surgery, American Vein and Lymphatic Society, Cardiovascular and Interventional Radiology Society of Europe, and American Heart Association. These guidelines were compared against the consensus statements obtained through the surveys to determine how they relate to Australian and New Zealand practice. In addition, selected key studies, reviews, and meta-analyses on venous stenting were discussed and added to the document. Finally, a selection of statements with >75% agreement was voted on, and barriers to the guideline's applicability were identified. RESULTS: The document addresses two key areas: patient selection and technical aspects of venous stenting. Regarding patient selection, patients with a CEAP (Clinical-Etiologic-Anatomic-Physiologic) score of ≥3 or a venous clinical severity score for pain of ≥2, or both, and evidence of >50% stenosis on venography, computed tomography venography, magnetic resonance venography, and/or intravascular ultrasound should be considered for venous stenting (level of recommendation Ib) Patients undergoing thrombus removal for acute iliofemoral deep vein thrombosis, in whom a culprit stenotic lesion has been uncovered, should be considered for venous stenting (level of recommendation Ib). Patients with chronic pelvic pain, deep dyspareunia, postcoital pain affecting their quality of life, when other causes have been ruled out, should be considered for venous stenting (level of recommendation Ic). Asymptomatic patients should not be offered venous stenting (level of recommendation IIIc). CONCLUSIONS: Patients with deep VOO have been underdiagnosed and undertreated for decades; however, in recent years, interest from physicians and industry has grown substantially. The advent of simpler and safer treatment options has revolutionized its management, but, unfortunately, formal training for venous disease has not grown at the same rate. Simplifying the technology and training required can result in inconsistent outcomes. These guidelines are aimed at developing standards of care and will serve as an educational platform for future developments.
引用
- Villalba L, Bayat I, Dubenec S, et al. RETRACTED: Australian and New Zealand Society for Vascular Surgery clinical practice guidelines on venous outflow Obstruction of the femoral-iliocaval veins. J Vasc Surg Venous Lymphat Disord. 2023. PMID: 37085086. doi:10.1016/j.jvsv.2023.02.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。